# AMJEVITA

NDC: 72511-482
Generic name: adalimumab-atto
Labeler / Manufacturer: Amgen USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20230814

FDA application: BLA761024

## Active ingredients

- ADALIMUMAB: 40 mg/.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72511-482"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72511-482
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7178e36-6787-45ab-8fee-be59bc6a4aa4